On the wire
HF
Wire Desk
Saturday, 21 November 2026
ai drug discovery

$7.1 Billion in Six Months: Isomorphic Labs Builds Toward Its First Human Trials

Isomorphic Labs raised $5 billion to expand its AI drug design platform and move its first drug candidates toward human trials after a $2.1 billion May round.

The post $7.1 Billion in Six Months: Isomorphic Labs Builds Toward Its First Human Trials appeared first on TechRepublic.

Advertisement
Originally published by TechRepublic. Read the original story →

Be the first to comment

Join the conversation

More From the Wire